Navigation Links
Jackson Laboratory professor emeritus Douglas Coleman wins BBVA, King Faisal awards
Date:1/29/2013

Bar Harbor, Maine -- Douglas Coleman, Ph.D., a retired Jackson Laboratory scientist whose work established the first clues to a genetic component in obesity, has won two major international science awards: the Frontiers of Knowledge Award in Biomedicine from the BBVA Foundation, based in Bilbao, Spain, and the King Faisal International Prize in Medicine from the Saudi Arabian King Faisal Foundation.

Coleman, 81, will share both prizes with Jeffrey Friedman, M.D., Ph.D., of Rockefeller University and the Howard Hughes Medical Institute.

"I'm delighted and honored to be sharing these awards with Jeff Friedman," Coleman said, adding that receiving news of both awards on Monday was "pretty amazing. It's like a hole in one!"

Coleman conducted his groundbreaking work in the 1950s and 1960s, with Friedman building on Coleman's discoveries from the 1990s to today. Together their work showed that chemical and genetic factors -- not just willpower and eating habits -- are involved in appetite control and obesity, opening possibilities for future pharmaceutical treatments. Their work also demonstrated that fat is not simply a passive energy-storage site, as previously thought, but is an endocrine organ that produces important hormones.

The BBVA Foundation will present its award to the scientists at a ceremony in Spain in June. The Frontiers of Knowledge Award in Biomedicine includes a 400,000-Euro (about $540,000) cash gift to be shared by the scientists. The Foundation is affiliated with BBVA (Banco Bilbao Vizcaya Argentaria), one of Spain's largest banks.

In the announcement for the prestigious King Faisal International Prize in Medicine, the organizers noted that the scientists' work in identifying and characterizing the pathway of the hormone leptin "has had a major impact on our understanding of the biology of obesity," adding that this work provides "more illuminating views of the endocrine system."

At a ceremony in Riyadh, Saudi Arabia, in March, the scientists will each receive a certificate, a gold medal and a cash endowment of $100,000. The King Faisal International Prize in Medicine has been awarded annually since 1981. The King Faisal Foundation was established in 1977 by the late King Faisal ibn Abd Al Aziz, a son of Saudia Arabia's founder.

The BBVN Foundation and King Faisal Foundation awards are the latest of several major scientific prizes that Drs. Coleman and Friedman have won. In October 2009, they received the Shaw Prize, the so-called "Nobel of the East," at a ceremony in Hong Kong. And on Oct. 1, 2010, they accepted the Albert Lasker Basic Medical Research Award in New York. Coleman's other honors include election to the National Academy of Sciences in 1998 and the 2005 Gairdner Foundation Award.


'/>"/>

Contact: Joyce Peterson
joyce.peterson@jax.org
207-288-6058
Jackson Laboratory
Source:Eurekalert  

Related biology news :

1. Jackson Laboratory researchers provide definitive proof for receptors role in synapse development
2. Labor der Zukunft -- Tomorrows laboratory technology
3. Story tips From the Department of Energys Oak Ridge National Laboratory, March 2012
4. Global Laboratory Automation Industry
5. Its a trap! New laboratory technique captures microRNA targets
6. Story tips from the Department of Energys Oak Ridge National Laboratory, July 2012
7. Neurons made from stem cells drive brain activity after transplantation in laboratory model
8. January 2013 story tips from Oak Ridge National Laboratory
9. Study by Haverford College professor reveals unprecedented impact of Deepwater Horizon on deep ocean
10. A University of Tennessee professors hypothesis may be game changer for evolutionary theory
11. Scripps Research Institute Professor Gerald F. Joyce elected to American Academy of Arts & Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Jackson Laboratory professor emeritus Douglas Coleman wins BBVA, King Faisal awards
(Date:2/7/2017)... Minn. , Feb. 7, 2017   MedNet ... supports the entire spectrum of clinical research, is pleased ... iMedNet , its innovative, highly flexible and award ... iMedNet customers. iMedNet is a proven ... provides Electronic Data Capture (EDC), but also delivers an ...
(Date:2/3/2017)... , Feb. 3, 2017 A new independent ... Strategy Partners, LLP (IdSP) . Designed to fill a ... complex identity market, founding partners Mark Crego ... combined years just in identity expertise that span federal ... non-profit leadership. The Crego-Kephart combined expertise has a common ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, LLC, ... for the treatment of bacterial infections, today announced ... antibacterial candidates from Pro Bono Bio Ltd (PBB) ... of multi-drug resistant forms of Gram-negative bacteria.   The ... Infectives Ltd, a PBB group company. ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... Feb. 27, 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: ... on Friday, February 24, 2017 a total of 10,672,750 common ... $0.13 per common share. Proceeds from the exercise of these ... InMed,s Treasury.   ... "We are grateful for this expression of confidence by ...
(Date:2/27/2017)... NEW YORK , February 27, 2017 ... up by Stock-Callers.com for evaluation today, and they are: ... ARWR), Pacific Biosciences of California Inc. (NASDAQ: PACB), and ... to an article on ETF Trends, market observers are ... Congress and administration could enact reforms to free cash ...
(Date:2/27/2017)... , Feb. 27, 2017 Fluxion Biosciences announced ... has been appointed as a Certified Service ... IsoFlux system will be used in Genetracer Biotech,s novel ... lung and colon cancer, with plans to move to ... is utilizing Fluxion,s IsoFlux System to isolate, recover, and ...
(Date:2/27/2017)... ... 27, 2017 , ... The Catalyst Midwest premix manufacturing facility has ... premix services and private label organic services. , The first organic product is Organic ... operating officer of Dynamite Marketing, which owns the facility. , Catalyst already has received ...
Breaking Biology Technology: